Nanjing Chia-tai Tianqing Pharmaceutical

This phase 3 trial tested the drug elagolix in 202 women with moderate to severe pain from endometriosis. Participants took either elagolix or a placebo for 12 weeks. The study measured how well the drug reduced menstrual cramps and pelvic pain. The goal is to see if elagolix can…